rhBMP-2
rhBMP-2 has been studied in 2 papers since 2020: none in people yet, 1 in animals, 1 in cells; 1 in the past year. The research so far is in animals and cells. The newest paper, Jan 28, 2026: “Co-Treatment With rhBMP-2 and Rapamycin Modulates Osteogenesis-Adipogenesis Balance to Enhance Aged Bone Regeneration”.
2 papers study it6 findingsUpdated
At a glance
The findings reach cells, none yet in people. 2 independent labs in 2 countries; 1 trial, none about aging.
None of its findings points the other way.
- 2 independent labs in 2 countries
- 1 trial, none about aging
- Funders: National Key Research and Development Program of China and 1 more
- Animals1
- Cells1
What did studies of rhBMP-2 find?
6Studies of rhBMP-2 measured 6 outcomes, among them Osteogenic response, Excess adipocyte accumulation and P16.
Osteogenic response
downin cells1
1 study
Osteogenic response
downin cells1
rhBMP-2 decreases osteogenic response in senescent bone marrow stromal cells.
“rhBMP-2 is found to exacerbate the imbalance between osteogenesis and adipogenesis in senescent bone marrow stromal cells (BMSCs), resulting in excess adipocytes (eADs) accumulation and a diminished osteogenic response”
Cellsin senescent bone marrow stromal cellsrecombinant human
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Excess adipocyte accumulation
upin cells1
1 study
Excess adipocyte accumulation
upin cells1
rhBMP-2 increases excess adipocyte accumulation in senescent bone marrow stromal cells.
“rhBMP-2 is found to exacerbate the imbalance between osteogenesis and adipogenesis in senescent bone marrow stromal cells (BMSCs), resulting in excess adipocytes (eADs) accumulation and a diminished osteogenic response”
Cellsin senescent bone marrow stromal cellsrecombinant human
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
P16
upin human cells1
1 study
P16
upin human cells1
rhBMP-2 increases P16 in human cells (p53 and p21 showed the same pattern).
“The expression of p53, p21, and p16 in both low and high dose rhBMP-2 groups increased in all passages compared to the control group.”
Cellsp53 and p21 showed the same patternrecombinant humannucleus pulposus cellslow and high dose
Biotechnic & histochemistry : official publication of the Biological Stain Commission
Cellular senescence
upin human cells1
1 study
Cellular senescence
upin human cells1
rhBMP-2 increases cellular senescence in human cells (measured as SA-β-gal-positive cells with passaging).
“The percentage of SA-β-gal-positive NPCs increased more rapidly in the high-dose rhBMP-2 group with passaging compared to the control and low-dose rhBMP-2 groups.”
Cellsmeasured as SA-β-gal-positive cells with passagingrecombinant humannucleus pulposus cellshigh-dose
Biotechnic & histochemistry : official publication of the Biological Stain Commission
Telomerase activity
upin human cells1
1 study
Telomerase activity
upin human cells1
rhBMP-2 increases telomerase activity in human cells (serial passaging to end of replicative lifespan).
“Mean telomerase activity was significantly greater in the high-dose rhBMP-2 group compared to the control and low-dose rhBMP-2 groups.”
Cellsserial passaging to end of replicative lifespanrecombinant humannucleus pulposus cellshigh-dose
Biotechnic & histochemistry : official publication of the Biological Stain Commission
Replicative capacity
downin human cells1
1 study
Replicative capacity
downin human cells1
rhBMP-2 decreases replicative capacity in human cells (serial passaging to end of replicative lifespan).
“The replicative capacity of NPCs in the high-dose rhBMP-2 group was decreased significantly compared to the control and low-dose rhBMP-2 groups.”
Cellsserial passaging to end of replicative lifespanrecombinant humannucleus pulposus cellshigh-dose
Biotechnic & histochemistry : official publication of the Biological Stain Commission
Trial sponsors
Company1 trialPhase 250 people